Patents by Inventor Arnoldo Barbosa

Arnoldo Barbosa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8268615
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) LSA-NRC polypeptide. The method of the present invention produces a highly purified polypeptide which is useful as a vaccine and as a diagnostic reagent.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: September 18, 2012
    Assignee: The United States of America as Represented by the Secretary of the Army
    Inventors: David E. Lanar, Collette J. Hillier, Jeffrey A. Lyon, Evelina Angov, Sanjai Kumar, William Rogers, Arnoldo Barbosa
  • Publication number: 20100040640
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) LSA-NRC polypeptide. The method of the present invention produces a highly purified polypeptide which is useful as a vaccine and as a diagnostic reagent.
    Type: Application
    Filed: May 14, 2009
    Publication date: February 18, 2010
    Inventors: David E. Lanar, Collette J. Hillier, Jeffrey A. Lyon, Evelina Angov, Sanjai Kumar, William Rogers, Arnoldo Barbosa
  • Patent number: 7550275
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) LSA-NRC polypeptide. The method of the present invention produces a highly purified polypeptide which is useful as a vaccine and as a diagnostic reagent.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: June 23, 2009
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: David E. Lanar, Collette J. Hillier, Jeffrey A. Lyon, Evelina Angov, Sanjai Kumar, William Rogers, Arnoldo Barbosa
  • Publication number: 20060088547
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) LSA-NRC polypeptide. The method of the present invention produces a highly purified polypeptide which is useful as a vaccine and as a diagnostic reagent.
    Type: Application
    Filed: November 12, 2003
    Publication date: April 27, 2006
    Inventors: David Lanar, Collette Hillier, Jeffrey Lyon, Evelina Angov, Sanjai Kumar, William Rogers, Arnoldo Barbosa